• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Abu Dhabi’s Rizek ’First App in the World’ to Offer At-home Vaccine Bookings

Share:

April 10, 2021

An Abu Dhabi-based startup is claiming it has become the “first app in the world” to offer bookings for at-home COVID-19 vaccinations.

Rizek, which specializes in on-demand personal and home services – such as DIY, tutoring, and beauty and wellness – has added a feature that enables anyone, subject to their location in the United Arab Emirates (UAE), to book a private COVID-19 vaccine to be conducted by a licensed professional at home.

The service doesn’t come cheap, however. According to the app, bookings start from AED 1,300 (approx. $354).

“Since our inception, we have been continuously raising the bar of customer-centric services, achieving several milestones over the past year alone that culminated into Rizek becoming the only app in the world to offer at-home COVID-19 vaccinations,” said Rizek founder and CEO, Abdallah Abu Sheikh. “This is an initiative that could not have been realized without the fundamental support that the UAE government and its leadership offer to everyone.”

THE LARGER CONTEXT

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

According to the UAE’s Ministry of Health and Prevention (MoHAP), the total number of doses administered now stands at 8.22 million, bringing the rate of doses to 83.12 per 100 people.

Four vaccines are currently being offered in the country: Sinopharm, Pfizer-BioNTech, Sputnik V, and Oxford-AstraZeneca.

Prior to the vaccines being made available, Rizek – which was founded in 2019 – became the first non-healthcare app of its kind to introduce COVID-19 PCR testing in September 2020. Earlier this month, the company announced it has helped facilitate more than 100,000 COVID-19 PCR tests to date.

ON THE RECORD

Rizek co-founder Ahmed Mazroui added: “We are proud to be aligned with national initiatives to limit and stop the spread of COVID-19. We have continuously evolved our services to surpass the needs of the overarching UAE community, and by establishing the infrastructure to provide at-home PCR tests, we [were] the first app in the region and the Middle East to be doing so.”

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Verily Launches COVID-19 Pathfinder for Health Systems & HospitalsVerily Launches COVID-19 Pathfinder for Health Systems & Hospitals
  • Cresco Labs Announces Regulatory Approval For Acquisition Of One Of Ten Vertically Integrated Licenses In New York StateCresco Labs Announces Regulatory Approval For Acquisition Of One Of Ten Vertically Integrated Licenses In New York State
  • Recipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc. and resolve on share issuesRecipharm completes acquisition of Kemwell AB and Cirrus Pharmaceuticals Inc. and resolve on share issues
  • Jasper Therapeutics Announces Expansion of Series a Financing, Bringing Total Corporate Fundraising to More Than $50 MillionJasper Therapeutics Announces Expansion of Series a Financing, Bringing Total Corporate Fundraising to More Than $50 Million
  • Worldwide M&A activity predicted to hit new high in 2018, but imbalances growWorldwide M&A activity predicted to hit new high in 2018, but imbalances grow
  • Mobihealthnews’ Predictions for 2020: Big Tech’s Here to Stay, Digital Health Moves Through Gartner Hype Cycle and MoreMobihealthnews’ Predictions for 2020: Big Tech’s Here to Stay, Digital Health Moves Through Gartner Hype Cycle and More
  • Arteaus Therapeutics Sells Emgality Royalty for $260 MillionArteaus Therapeutics Sells Emgality Royalty for $260 Million
  • Eidos Receives Non-Binding Bid From BridgeBio For Remaining SharesEidos Receives Non-Binding Bid From BridgeBio For Remaining Shares

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications